453 results on '"Memeo, Lorenzo"'
Search Results
2. Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
3. Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
4. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection
5. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
6. Analysis by TeloView ® Technology Predicts the Response of Hodgkin's Lymphoma to First-Line ABVD Therapy.
7. Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to first line ABVD Therapy
8. ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation.
9. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
10. Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death
11. The effect of environmental chemicals on the tumor microenvironment
12. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
13. Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist’s Perspective
14. History of Immunohistochemistry
15. Exposure to emissions from Mount Etna (Sicily, Italy) and incidence of thyroid cancer: a geographic analysis
16. The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists’ perspective
17. Data from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
18. Supplementary Figure 1 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
19. Supplementary Table 2 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
20. Supplementary Table 1 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
21. Unique Osteoid Osteoma of the Frontal Sinus from the Late Roman Empire
22. Data from 3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
23. Supplementary Figure 2 from BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
24. Supplementary Information, Methods, Table 1, Figures 1-7 from 3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
25. Supplementary Figure 1 from PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma
26. Supplementary Figure 3 from BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
27. Supplementary Figure 2 from PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma
28. Supplementary Figure 1 from BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
29. Data from BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
30. Supplementary Material from PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma
31. Supplementary Figure 4 from BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
32. Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons
33. Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
34. Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done
35. Gene Expression Analysis for the Identification of Genes Involved in Early Tumour Development
36. Endoscopic laser en bloc removal of bladder tumor. Surgical radicality and improvement of the pathological diagnostic accuracy
37. Associations between Polycyclic Aromatic Hydrocarbon—Related Exposures and p53 Mutations in Breast Tumors
38. Poor Prognosis in Carcinoma Is Associated with a Gene Expression Signature of Aberrant PTEN Tumor Suppressor Pathway Activity
39. Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features
40. Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review
41. STARD3: A Prospective Target for Cancer Therapy
42. Clear Cell Carcinoma Arising in an Abdominal Wall Cesarean Section Scar: A Case Report With Description of Pathological and Molecular Features
43. Sclerosing Mesenteritis, a Rare Cause of Mesenteric Mass in a Young Adult: A Case Report
44. Cancer Organoids in Basic Science and Translational Medicine
45. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis
46. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
47. Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions
48. Environmental immune disruptors, inflammation and cancer risk
49. Causes of genome instability: the effect of low dose chemical exposures in modern society
50. Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.